SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year engine, technology-licensing, and engineering-support agreement with AST SpaceMobile is driving attention, with traders viewing it as validation of Fireflys propulsion business and a boost to its backlog. The reaction is broadly bullish, though some question the deals cash-versus-stock terms, potential dilution, and execution risks ahead of earnings.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

ONDS is drawing attention after a sharp rebound following a prolonged selloff, with traders debating whether the move reflects short covering and options activity or is only a temporary bounce. The discussion is focused on the upcoming earnings report as a potential test of whether recent growth and contract wins are translating into results, alongside concerns about dilution and weak price momentum.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor is drawing attention ahead of the FDAs pending decision on deramiocel for Duchenne muscular dystrophy, with traders focused on whether HOPE-3 upper-limb data and advocacy from trial investigators will support approval. The discussion is divided between bullish approval and short-squeeze expectations and concerns that the FDA may reject the application or request more evidence; the outcome remains uncertain.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos Q3 update, large cash position and agreement to reserve manufacturing capacity for future reactor components are driving a sharp rebound and bullish options activity. Traders remain divided, with skeptics pointing to limited current revenue, a long commercialization timeline and dilution concerns.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of Grand Theft Auto VIs launch and earnings, with traders focused on expected demand, preorder disclosures and the games potential online revenue. Bulls see substantial long-term upside, while skeptics warn the launch may already be priced in and point to sell-the-news, leak and delay risks amid the stocks recent weakness.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold is under pressure as a stronger-than-expected U.S. jobs report and a firmer dollar have reinforced expectations of a hawkish Fed, prompting traders to question its safe-haven appeal. The community is split between expecting further downside and viewing the pullback as a buying opportunity, with some noting gold has held up better than expected.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs strong quarterly results and raised full-year revenue outlook are driving attention, with traders also pointing to a growing backlog and quantum-sector momentum. Bulls view the report as evidence of commercial progress, while skeptics cite cash burn, acquisition-driven revenue and dilution risks.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels Q3 results triggered a sharp selloff, with traders debating whether weaker-than-hoped earnings and profitability outweigh product growth and updated revenue guidance. Bulls point to VEPPANUs early launch traction and upcoming R289 data, while skeptics question how quickly VEPPANU sales can scale and whether the quarter met expectations.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.21896617 USD and is down -6.75 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,821,731,810.20 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs weakness and stalled price action are prompting debate over regulatory uncertainty: traders worry the political shift could delay the Clarity Act, while others argue XRPs tokenomics and limited demonstrated utilitynot politicsare the bigger concern. Dip buyers remain bullish, but frustration with Ripple and its escrow releases is also prominent.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

A Form 4 reporting a roughly $24 million Baker Bros. Advisors purchase of 247,090 Kodiak shares is drawing attention. Some traders view the buying as a vote of confidence, while others question whether a share offering or further dilution could follow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ZS If SentinelOne continues to grow its revenue at a steady rate of 20% annually, it will attain approximately $3.0 billion in revenue by Fiscal Year 2032, which corresponds to the calendar year 2031.  
  
ZS has $3B in sales and sports a .... $33B market cap  
  
S.....currently sports a .....................$7B market cap  
  
S.....has 5x potential over the next 5 years 
 
SentinelOne(S) has zero debt, $2B in cash, is a 
 21-22% rev grower and has a more advanced AI-centric cybersecurity platform than MSFT, CRWD and PANW, as seen below: 
 
https://www.sentinelone.com/vs/competition/?utm_source=https%3A%2F%2Fwww.google.com%2F&amp;utm_medium=organic-search

StockTwits Web

Zscaler Inc

 If SentinelOne continues to grow its revenue at a steady rate of 20% annually, it will attain approximately $3.0 billion in revenue by Fiscal Year 2032, which corresponds to the calendar year 2031.  
  
ZS has $3B in sales and sports a .... $33B market cap  
  
S.....currently sports a .....................$7B market cap  
  
S.....has 5x potential over the next 5 years 
 
SentinelOne(S) has zero debt, $2B in cash, is a 
 21-22% rev grower and has a more advanced AI-centric cybersecurity platform than MSFT, CRWD and PANW, as seen below: 
 


DeepValueStocks

$ZS SentinelOne(S) also trades at just....7x....trailing sales

 SentinelOne(S) also trades at just....7x....trailing sales

$ZS In summary, SentinelOne(S) is a..... &quot;baby ZS&quot;

 In summary, SentinelOne(S) is a..... "baby ZS"

$ZS  
                                        Forward Revenue Growth (FY27)  
ZS                                                            17% 
S                                                               20.3% 
 
S   =     Higher rev growth, with a lower.....P/S ratio

  
                                        Forward Revenue Growth (FY27)  
ZS                                                            17% 
S                                                               20.3% 
 
S   =     Higher rev growth, with a lower.....P/S ratio